DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹9,360 Cr | ₹7,845 Cr | ₹7,767 Cr | ₹8,960 Cr | ₹6,969 Cr |
What is the latest Revenue of DIVIS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹9,360 Cr |
| Mar2024 | ₹7,845 Cr |
| Mar2023 | ₹7,767 Cr |
| Mar2022 | ₹8,960 Cr |
| Mar2021 | ₹6,969 Cr |
How is Revenue of DIVIS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,360 Cr | 19.31 | |
| Mar2024 | ₹7,845 Cr | 1.00 | |
| Mar2023 | ₹7,767 Cr | -13.31 | |
| Mar2022 | ₹8,960 Cr | 28.56 | |
| Mar2021 | ₹6,969 Cr | - | |
Compare Revenue of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,434.1 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
| MANKIND PHARMA | ₹86,802.6 Cr | -0.7% | -5.7% | -20.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.2% |
-7.2% |
1.3% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses